Meropenem is an ultra-broad-spectrum injectable antibacterial acclimated to amusement a advanced array of infections. It is a β-lactam and belongs to the subgroup of carbapenem, agnate to imipenem and ertapenem. Meropenem was originally developed by Dainippon Sumitomo Pharma. It acquired US FDA approval in July 1996. It penetrates able-bodied into abounding tissues and physique fluids, including cerebrospinal fluid, bile, affection valve, lung, and peritoneal fluid. It was initially marketed by AstraZeneca beneath the barter name Merrem, and is now accessible in abounding countries as a generic.
Treating infections acquired by assertive bacteria.
Meropenem is a carbapenem antibiotic. It kills bacilli by blocking the advance of the bacteria's corpuscle wall.
from:Natural standard substance
No comments:
Post a Comment